Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Jing-Jin Electric Technologies
688280
5
Hangzhou Anysoft Information Technology
300571
US Stock MarketDetailed Quotes
BCAB BioAtla
- 0.4449
- +0.0043+0.98%
Close Apr 28 16:00 ET
25.98MMarket Cap-0.31P/E (TTM)
0.4535High0.4301Low417.37KVolume0.4405Open0.4406Pre Close183.99KTurnover0.99%Turnover RatioLossP/E (Static)58.40MShares3.420052wk High1.82P/B18.82MFloat Cap0.240052wk Low--Dividend TTM42.30MShs Float76.6300Historical High--Div YieldTTM5.31%Amplitude0.2400Historical Low0.4400Avg Price1Lot Size
About BioAtla Company
BioAtla, Inc. engages in the development of novel class of specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its CAB portfolio include MABs & ADCS, BA3011, and BA3021. The company was founded by Jay M. Short and Carolyn Anderson in March 2007 and is headquartered in San Diego, CA.
Company Profile
SymbolBCAB
Company NameBioAtla
Listing DateDec 16, 2020
Issue Price18.00
Founded2007
CEODr. Jay M. Short,PhD
MarketNASDAQ
Employees61
Fiscal Year Ends12-31
Address11085 Torreyana Road
CitySan Diego
ProvinceCalifornia
CountryUnited States of America
Zip Code92121
Phone1-858-558-0708
Websitehttp://www.BioAtla.com
Company Executives
- Name
- Position
- Salary
- Dr. Jay M. Short,PhD
- Chairman of the Board and Chief Executive Officer
- 1.95M
- Richard A. Waldron
- Senior Vice President, Chief Financial Officer and Principal Accounting Officer
- 881.70K
- Christian Vasquez
- Chief Accounting Officer, Controller and Corporate Secretary
- --
- Dr. Eric Sievers, M.D.
- Chief Medical Officer
- 961.08K
- Scott A. Smith
- Director
- 65.91K
- Professor Lawrence J. Steinman, M.D.
- Lead Independent Director
- 89.96K
- Sylvia McBrinn
- Independent Director
- 83.41K
- Edward Williams
- Independent Director
- 61.53K
- Dr. Susan Moran, M.D.
- Independent Director
- 74.91K
- Dr. Mary Ann Gray,PhD
- Independent Director
- 70.16K
Market Insights
Discussing
2025 Buffett shareholders' meeting: What's the new buzz in value investing?
🎙️Discussion 1. In the face of market changes, do you prefer to stick with growth stocks or switch to value stocks? 2. Based on the current
Moomoo News Global
Apr 28 18:10
Warren Buffett Stands Tall as U.S. Stocks Tumble: How the 'Oracle' Is Tackling Tariff Impacts
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock Now
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now